newsfilter
← Latest News
Business Wire·

Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Epizyme (NASDAQ:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering transformative therapies for cancer patients against novel epigenetic targets, today announced that the Company has granted equity awards to